PL2281822T3 - Nowe pochodne dihydroindolonów, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne - Google Patents

Nowe pochodne dihydroindolonów, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne

Info

Publication number
PL2281822T3
PL2281822T3 PL10290436T PL10290436T PL2281822T3 PL 2281822 T3 PL2281822 T3 PL 2281822T3 PL 10290436 T PL10290436 T PL 10290436T PL 10290436 T PL10290436 T PL 10290436T PL 2281822 T3 PL2281822 T3 PL 2281822T3
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
compositions containing
preparing same
new
derivatives
Prior art date
Application number
PL10290436T
Other languages
English (en)
Inventor
Jean-Claude Ortuno
Alexis Cordi
Jean-Michel Lacoste
Imre Fejes
Michael Burbridge
John Hickman
Alain Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2281822T3 publication Critical patent/PL2281822T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Storage Device Security (AREA)
  • Computer And Data Communications (AREA)
PL10290436T 2009-08-04 2010-08-03 Nowe pochodne dihydroindolonów, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne PL2281822T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0903839A FR2948940B1 (fr) 2009-08-04 2009-08-04 Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP10290436A EP2281822B1 (fr) 2009-08-04 2010-08-03 Nouveaux dérivés dihydroindolones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PL2281822T3 true PL2281822T3 (pl) 2013-06-28

Family

ID=41796204

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10290436T PL2281822T3 (pl) 2009-08-04 2010-08-03 Nowe pochodne dihydroindolonów, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne

Country Status (42)

Country Link
US (3) US8133889B2 (pl)
EP (1) EP2281822B1 (pl)
JP (2) JP5475588B2 (pl)
KR (1) KR101309101B1 (pl)
CN (1) CN101987848B (pl)
AP (1) AP2756A (pl)
AR (1) AR077510A1 (pl)
AU (1) AU2010203305B2 (pl)
BR (1) BRPI1003241A2 (pl)
CA (1) CA2710224C (pl)
CL (1) CL2010000804A1 (pl)
CO (1) CO6320143A1 (pl)
CU (1) CU23921B1 (pl)
CY (1) CY1113914T1 (pl)
DK (1) DK2281822T3 (pl)
EA (1) EA019481B1 (pl)
EC (1) ECSP10010380A (pl)
ES (1) ES2403227T3 (pl)
FR (1) FR2948940B1 (pl)
GE (1) GEP20125548B (pl)
HN (1) HN2010001537A (pl)
HR (1) HRP20130327T1 (pl)
IL (1) IL207183A (pl)
JO (1) JO2808B1 (pl)
MA (1) MA32184B1 (pl)
ME (1) ME01491B (pl)
MX (1) MX2010008557A (pl)
MY (1) MY183326A (pl)
NI (1) NI201000134A (pl)
NZ (1) NZ586993A (pl)
PE (1) PE20110206A1 (pl)
PL (1) PL2281822T3 (pl)
PT (1) PT2281822E (pl)
RS (1) RS52701B (pl)
SA (1) SA110310634B1 (pl)
SG (1) SG168499A1 (pl)
SI (1) SI2281822T1 (pl)
TW (1) TWI408138B (pl)
UA (1) UA105357C2 (pl)
UY (1) UY32801A (pl)
WO (1) WO2011015728A1 (pl)
ZA (1) ZA201005424B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008411B1 (fr) * 2013-07-12 2015-07-03 Servier Lab Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent
US10245270B2 (en) * 2013-07-12 2019-04-02 Les Laboratoires Servier Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr
US10343991B2 (en) * 2016-11-02 2019-07-09 Council Of Scientific & Industrial Research C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
AU2020215088A1 (en) 2019-02-01 2021-07-22 Bayer Aktiengesellschaft 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
CN113845524B (zh) * 2021-10-29 2023-11-07 四川农业大学 一种螺吡咯吲哚酮类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892248A (ja) * 1994-09-26 1996-04-09 Yamanouchi Pharmaceut Co Ltd インドリノン誘導体
AU5468499A (en) * 1998-08-04 2000-02-28 Sugen, Inc. 3-methylidenyl-2-indolinone modulators of protein kinase
JP2002532492A (ja) * 1998-12-17 2002-10-02 エフ.ホフマン−ラ ロシュ アーゲー サイクリン−依存性キナーゼ、特にcdk2のインヒビターとしての4−アルケニル(及びアルキニル)オキシドール
CA2377513A1 (en) 1999-06-25 2001-01-04 Universitat Zurich Hetero-associating coiled-coil peptides
DE122008000002I1 (de) * 2000-02-15 2008-04-17 Sugen Inc Pyrrol substituierte indolin-2-on protein kinase inhibitoren
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP1458713B1 (en) * 2001-12-27 2005-08-24 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
AU2004284084A1 (en) * 2003-10-24 2005-05-06 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer
US7378530B2 (en) 2005-02-22 2008-05-27 Nereus Pharmaceuticals, Inc. Anti-cancer and anti-microbial 5-membered heterocyclic compounds
BRPI0620939A2 (pt) * 2005-12-29 2011-11-29 Scripps Research Inst derivados de aminoácido de indolinona com base em inibidores de proteìna quinase
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ME01491B (me) 2014-04-20
EP2281822A1 (fr) 2011-02-09
US20120046287A1 (en) 2012-02-23
HRP20130327T1 (hr) 2013-05-31
MA32184B1 (fr) 2011-04-01
UA105357C2 (uk) 2014-05-12
ECSP10010380A (es) 2011-03-31
CL2010000804A1 (es) 2011-08-26
JP5538580B2 (ja) 2014-07-02
CU20100157A7 (es) 2012-03-15
AP2010005343A0 (en) 2010-08-31
HK1155742A1 (en) 2012-05-25
CA2710224C (fr) 2013-01-08
JP5475588B2 (ja) 2014-04-16
GEP20125548B (en) 2012-05-25
MX2010008557A (es) 2011-02-03
IL207183A0 (en) 2010-12-30
KR101309101B1 (ko) 2013-09-16
FR2948940A1 (fr) 2011-02-11
CA2710224A1 (fr) 2011-02-04
CN101987848A (zh) 2011-03-23
CY1113914T1 (el) 2016-07-27
EA019481B1 (ru) 2014-04-30
CN101987848B (zh) 2014-06-18
AP2756A (en) 2013-09-30
PT2281822E (pt) 2013-02-27
EA201001087A1 (ru) 2011-04-29
US20130331380A1 (en) 2013-12-12
PE20110206A1 (es) 2011-04-09
TW201118092A (en) 2011-06-01
WO2011015728A1 (fr) 2011-02-10
TWI408138B (zh) 2013-09-11
AU2010203305A1 (en) 2011-02-24
DK2281822T3 (da) 2013-04-22
US8653073B2 (en) 2014-02-18
SA110310634B1 (ar) 2013-11-10
JO2808B1 (en) 2014-09-15
US20110034460A1 (en) 2011-02-10
BRPI1003241A2 (pt) 2012-04-10
JP2011037848A (ja) 2011-02-24
IL207183A (en) 2014-01-30
AU2010203305B2 (en) 2015-02-05
US8541412B2 (en) 2013-09-24
CO6320143A1 (es) 2011-09-20
ZA201005424B (en) 2011-04-28
KR20110014116A (ko) 2011-02-10
HN2010001537A (es) 2013-05-06
SI2281822T1 (sl) 2013-04-30
US8133889B2 (en) 2012-03-13
RS52701B (sr) 2013-08-30
UY32801A (es) 2011-01-31
AR077510A1 (es) 2011-08-31
EP2281822B1 (fr) 2013-01-16
CU23921B1 (es) 2013-07-31
JP2013116908A (ja) 2013-06-13
SG168499A1 (en) 2011-02-28
FR2948940B1 (fr) 2011-07-22
MY183326A (en) 2021-02-18
NI201000134A (es) 2014-02-11
NZ586993A (en) 2012-01-12
ES2403227T3 (es) 2013-05-16

Similar Documents

Publication Publication Date Title
IL214822A0 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
IL214175A (en) Derivatives of aminotetralin, their pharmaceutical compositions and their use
SI2281822T1 (sl) Novi derivati dihidroindolona, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
IL219602A0 (en) Tricylic pyrazol amine derivatives, their preparation and pharmaceutical compositions containing them
IL225626A0 (en) The history of pyrrolidinone, their preparation and remote preparations containing them
PL2562172T3 (pl) Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
PL2107055T3 (pl) Nowe pochodne diosmetyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL217729A (en) History 3 - [(piperazine-1-yl) butyl] -h4-croman-4-one, processes for their preparation and pharmaceutical preparations containing them
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
SI1953161T1 (sl) Novi tricikliäśni derivati, postopek priprave le-teh in farmacevtski sestavki, ki jih vsebujejo
IL214907A (en) Derivatives of benzothiazines, methods for their preparation and medicinal compounds containing them
PT2448927E (pt) Novos derivados de (6-oxo-1,6-di-hidro-pirimidin-2-il)-amida, sua preparação e sua utilização farmacêutica como inibidores da fosforilação de akt
IL221244A0 (en) Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
PL2504331T3 (pl) Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie
IL230219B (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
SI2147915T1 (sl) Novi cikloalkilirani benzotiadiazinski derivati postopek za njihovo pripravo in farmacevtski sestavki ki jih vsebujejo
EP2424533A4 (en) SUBSTITUTED ISOQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE AS-SECRETASE INHIBITORS
IL233199B (en) History of heterocyclic carboxamides, their preparation and pharmaceutical preparations containing them
ZA201303692B (en) Diphenyl-amine derivatives:uses,process of synthesis and pharmaceutical compositions
GB201210536D0 (en) Composition, use and method of preparation thereof
EP2393361A4 (en) PHARMACEUTICAL QUALITY PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL214704A (en) The history of oxazole pyridine, its preparation and its pharmaceutical preparations
PT1873140E (pt) Novos derivados naftalénicos, processo para a sua preparação e composições farmacêuticas que os contenham